286 related articles for article (PubMed ID: 9550326)
1. Human monoclonal antibody with T-cell-like specificity recognizes MHC class I self-peptide presented by HLA-DR1 on activated cells.
Wölpl A; Halder T; Kalbacher H; Neumeyer H; Siemoneit K; Goldmann SF; Eiermann TH
Tissue Antigens; 1998 Mar; 51(3):258-69. PubMed ID: 9550326
[TBL] [Abstract][Full Text] [Related]
2. Recognition of HLA-DR1/DRB1*0101 molecules presenting HLA-A2 derived peptides by a human recombinant antibody, Fab-5 A1.
Löffler D; Welschof M; Goldmann SF; Wölpl A
Eur J Immunogenet; 1998 Oct; 25(5):339-47. PubMed ID: 9805656
[TBL] [Abstract][Full Text] [Related]
3. A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.
Zhu X; Bavari S; Ulrich R; Sadegh-Nasseri S; Ferrone S; McHugh L; Mage M
Eur J Immunol; 1997 Aug; 27(8):1933-41. PubMed ID: 9295029
[TBL] [Abstract][Full Text] [Related]
4. Induction of CTL response by a minimal epitope vaccine in HLA A*0201/DR1 transgenic mice: dependence on HLA class II restricted T(H) response.
BenMohamed L; Krishnan R; Longmate J; Auge C; Low L; Primus J; Diamond DJ
Hum Immunol; 2000 Aug; 61(8):764-79. PubMed ID: 10980387
[TBL] [Abstract][Full Text] [Related]
5. The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line.
Dodi AI; Brett S; Nordeng T; Sidhu S; Batchelor RJ; Lombardi G; Bakke O; Lechler RI
Eur J Immunol; 1994 Jul; 24(7):1632-9. PubMed ID: 8026524
[TBL] [Abstract][Full Text] [Related]
6. Identification of prostatic acid phosphatase (PAP) specific HLA-DR1-restricted T-cell epitopes.
Johnson LE; McNeel DG
Prostate; 2012 May; 72(7):730-40. PubMed ID: 22529020
[TBL] [Abstract][Full Text] [Related]
7. Retrovirally transduced human dendritic cells can generate T cells recognizing multiple MHC class I and class II epitopes from the melanoma antigen glycoprotein 100.
Lapointe R; Royal RE; Reeves ME; Altomare I; Robbins PF; Hwu P
J Immunol; 2001 Oct; 167(8):4758-64. PubMed ID: 11591807
[TBL] [Abstract][Full Text] [Related]
8. Flexibility in T-cell receptor ligand repertoires depends on MHC and T-cell receptor clonotype.
Geluk A; van Meijgaarden KE; Ottenhoff TH
Immunology; 1997 Mar; 90(3):370-5. PubMed ID: 9155643
[TBL] [Abstract][Full Text] [Related]
9. T cell recognition of allopeptides in context of syngeneic MHC.
Liu Z; Braunstein NS; Suciu-Foca N
J Immunol; 1992 Jan; 148(1):35-40. PubMed ID: 1530797
[TBL] [Abstract][Full Text] [Related]
10. Is there MHC Class II restriction of the response to MHC Class I in transplant patients?
Papassavas AC; Barnardo MC; Bunce M; Welsh KI
Transplantation; 2002 Feb; 73(4):642-51. PubMed ID: 11889447
[TBL] [Abstract][Full Text] [Related]
11. Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.
Chornoguz O; Gapeev A; O'Neill MC; Ostrand-Rosenberg S
Mol Cell Proteomics; 2012 Nov; 11(11):1457-67. PubMed ID: 22942358
[TBL] [Abstract][Full Text] [Related]
12. Association of HLA-DR1 with the allergic response to the major mugwort pollen allergen: molecular background.
Knapp B; Fischer G; Van Hemelen D; Fae I; Maillere B; Ebner C; Schreiner W; Bohle B; Jahn-Schmid B
BMC Immunol; 2012 Aug; 13():43. PubMed ID: 22871092
[TBL] [Abstract][Full Text] [Related]
13. Induction of cytotoxic T-lymphocytes specific for malignant glioma by HLA dimer-based artificial antigen-presenting cells.
Xiaobing J; Xiaoling L; Ruen L; Fangcheng Z; Hongyang Z
Cancer Biother Radiopharm; 2007 Dec; 22(6):826-35. PubMed ID: 18158774
[TBL] [Abstract][Full Text] [Related]
14. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
Chicz RM; Urban RG; Lane WS; Gorga JC; Stern LJ; Vignali DA; Strominger JL
Nature; 1992 Aug; 358(6389):764-8. PubMed ID: 1380674
[TBL] [Abstract][Full Text] [Related]
15. T cell recognition of self-human histocompatibility leukocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR molecules.
Liu Z; Sun YK; Xi YP; Harris P; Suciu-Foca N
J Exp Med; 1992 Jun; 175(6):1663-8. PubMed ID: 1375267
[TBL] [Abstract][Full Text] [Related]
16. Involvement of class II beta-chain amino acid residues 85 and 86 in T-cell allorecognition.
Eckels DD; Geiger MJ; Sell TW; Gorski JA
Hum Immunol; 1990 Mar; 27(3):240-53. PubMed ID: 1692822
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
[TBL] [Abstract][Full Text] [Related]
18. 3-Layer-based analysis of peptide-MHC interaction: in silico prediction, peptide binding affinity and T cell activation in a relevant allergen-specific model.
Knapp B; Omasits U; Bohle B; Maillere B; Ebner C; Schreiner W; Jahn-Schmid B
Mol Immunol; 2009 May; 46(8-9):1839-44. PubMed ID: 19232439
[TBL] [Abstract][Full Text] [Related]
19. Major histocompatibility complex class I-restricted alloreactive CD4+ T cells.
Boyle LH; Goodall JC; Gaston JS
Immunology; 2004 May; 112(1):54-63. PubMed ID: 15096184
[TBL] [Abstract][Full Text] [Related]
20. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
